Conexeu Sciences, Inc. (CNXU)
2.56
-0.27
(-9.54%)
USD |
NASDAQ |
Oct 30, 16:00
2.56
0.00 (0.00%)
After-Hours: 16:15
Conexeu Sciences Cash from Operations (Quarterly) : -6.759M for July 31, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -6.759M |
| April 30, 2026 | -1.804M |
| Date | Value |
|---|---|
| January 31, 2026 | |
| April 30, 2025 | -0.4288M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Vericel Corp. | 16.19M |
| AbbVie, Inc. | 3.436B |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -0.684M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0414M |
| Cash from Financing (Quarterly) | 1.705M |
| Free Cash Flow Per Share (Quarterly) | -0.2482 |
| Free Cash Flow to Equity (Quarterly) | -6.873M |
| Free Cash Flow to Firm (Quarterly) | -6.797M |